N-Fmoc-N'-Boc-N'-isopropyl-L-lysine

Catalog No. :
ACAGQZ938
CAS No. :
201003-48-7
Molecular Formula :
C29H38N2O6
Molecular Weight :
510.63

IUPAC Name:N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-(tert-butoxycarbonyl)-N6-isopropyl-L-lysine

N-Fmoc-N'-Boc-N'-isopropyl-L-lysine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$220.00Login to see priceIn stockIn stock
100g95%$877.00Login to see priceIn stockIn stock
500g95%$3508.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Fmoc-N'-Boc-N'-isopropyl-L-lysine
IUPAC NameN2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-(tert-butoxycarbonyl)-N6-isopropyl-L-lysine
MDL No.MFCD00080276
Molecular FormulaC29H38N2O6
Molecular Weight510.63
SMILESO=C(O)[C@@H](NC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O)CCCCN(C(OC(C)(C)C)=O)C(C)C
InChI KeyLUGFCMICCJNLBC-VWLOTQADSA-N
SynonymN6-[(1,1-DIMETHYLETHOXY)CARBONYL]-N2-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-N6-(1-METHYLETHYL)-L-LYSINE | C29H38N2O6 | F10731 | BCP14624 | DS-6846 | (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-ylamino]hexanoic aci
CAS No.201003-48-7
PubChem CID51340513

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACAGQZ938 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAGQZ938 route product structure diagram
    ACAGQZ938201003-48-7 In Stock
Inquiry

2. ACAGQZ938 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAGQZ938 route product structure diagram
    ACAGQZ938201003-48-7 In Stock
Inquiry

Comments (0)